You have 9 free searches left this month | for more free features.

Difelikefalin

Showing 1 - 16 of 16

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Pruritus, Notalgia Paresthetica Trial in Coral Gables (difelikefalin 2.0 mg tablets, difelikefalin 1.0 mg tablets, difelikefalin

Recruiting
  • Pruritus
  • Notalgia Paresthetica
  • difelikefalin 2.0 mg tablets
  • +3 more
  • Coral Gables, Florida
    Cara Therapeutics Study Site
Aug 3, 2023

End Stage Renal Disease on Hemodialysis Trial in Beijing, Shijiazhuang (Difelikefalin Injection)

Recruiting
  • End Stage Renal Disease on Hemodialysis
  • Difelikefalin Injection
  • Beijing, China
  • +3 more
Jun 1, 2023

Chronic Kidney Diseases, Pruritus Trial (Difelikefalin 1 mg Oral Tablet, Placebo Oral Tablet)

Recruiting
  • Chronic Kidney Diseases
  • Pruritus
  • Difelikefalin 1 mg Oral Tablet
  • Placebo Oral Tablet
  • Northridge, California
  • +5 more
Dec 21, 2022

Uremic Pruritus Trial in China (Difelikefalin Injection, Placebo Injection)

Recruiting
  • Uremic Pruritus
  • Difelikefalin Injection
  • Placebo Injection
  • Baotou, China
  • +34 more
Jun 1, 2023

Pruritus, Atopic Dermatitis Trial (difelikefalin 0.25 mg, difelikefalin 0.5 mg, TCS Cream)

Recruiting
  • Pruritus
  • Atopic Dermatitis
  • difelikefalin 0.25 mg
  • +4 more
  • Scottsdale, Arizona
  • +36 more
Dec 21, 2022

Pruritus, Atopic Dermatitis Trial in Canada, United States (difelikefalin 0.25 mg, difelikefalin 0.5 mg, difelikefalin 1.0 mg)

Completed
  • Pruritus
  • Atopic Dermatitis
  • difelikefalin 0.25 mg
  • +3 more
  • Anniston, Alabama
  • +39 more
Mar 30, 2022

Pruritus, Notalgia Paresthetica Trial in Canada, United States (difelikefalin 2.0 mg, Placebo)

Completed
  • Pruritus
  • Notalgia Paresthetica
  • difelikefalin 2.0 mg
  • Placebo
  • Fort Smith, Arkansas
  • +35 more
Aug 1, 2022

Chronic Kidney Diseases, Pruritus Trial (Difelikefalin 1 mg Oral Tablet, Placebo Oral Tablet)

Recruiting
  • Chronic Kidney Diseases
  • Pruritus
  • Difelikefalin 1 mg Oral Tablet
  • Placebo Oral Tablet
  • Huntsville, Alabama
  • +51 more
Dec 21, 2022

Healthy Trial in Dallas (CR845 0.5 mcg/kg IV, CR845 3 mcg/kg IV, Moxifloxacin 400 mg Oral Tablet)

Completed
  • Healthy
  • CR845 0.5 mcg/kg IV
  • +3 more
  • Dallas, Texas
    Cara Therapeutics Study Site
Feb 20, 2020

Chronic Kidney Diseases, Pruritus Trial in United States (CR845 0.25 mg Oral Tablet, CR845 0.5 mg Oral Tablet, CR845 1 mg Oral

Completed
  • Chronic Kidney Diseases
  • Pruritus
  • CR845 0.25 mg Oral Tablet
  • +3 more
  • Birmingham, Alabama
  • +59 more
Oct 22, 2020

Uremic Pruritus Trial in Worldwide (CR845 0.5 mcg/kg)

Completed
  • Uremic Pruritus
  • CR845 0.5 mcg/kg
  • Escondido, California
  • +46 more
Sep 21, 2021

Hemodialysis, Healthy Trial in San Antonio ([14C] CR845)

Completed
  • Hemodialysis
  • Healthy
  • [14C] CR845
  • San Antonio, Texas
    Cara Therapeutics Study Site
Jul 23, 2019

Uremic Pruritus Trial in Puerto Rico, United States (CR845)

Completed
  • Uremic Pruritus
  • Chula Vista, California
  • +26 more
Sep 21, 2021

Osteoarthritis, Hip, Osteoarthritis, Knee, Arthritis Trial in United States (CR845 tablet 1 mg, CR845 tablet 2.5 mg, CR845

Completed
  • Osteoarthritis, Hip
  • +5 more
  • CR845 tablet 1 mg
  • +3 more
  • Birmingham, Alabama
  • +34 more
Oct 19, 2020

Uremic Pruritus Trial in United States (CR845 0.5 mcg/kg, CR845 1 mcg/kg, CR845 1.5mcg/kg)

Completed
  • Uremic Pruritus
  • CR845 0.5 mcg/kg
  • +3 more
  • Phoenix, Arizona
  • +28 more
Jul 15, 2020

Post Abdominal Surgery Pain Trial in United States (CR845 IV 1 mcg/kg, CR845 IV 0.5 mcg/kg, Placebo IV)

Completed
  • Post Abdominal Surgery Pain
  • CR845 IV 1 mcg/kg
  • +2 more
  • Sheffield, Alabama
  • +22 more
May 22, 2019